1. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022) Authors: James, Nicholas D.; Clarke, Noel W.; Cook, Adrian; Ali, Adnan; Hoyle, Alex P.; Attard, Gerhardt; Brawley, Christopher D.; Chowdhury, Simon; Cross, William R.; Dearnaley, David P.; de Bono, Johann S.; Diaz‐Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J.; Langley, R... Journal: International journal of cancer Issue: Volume 151:Issue 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗